Enzymatics was founded on the principle that in order to fully unlock the potential of high resolution nucleic acid tests, it is imperative that we consistently manufacture our enzymes to an uncompromised level of performance and contamination specifications, even at industrial production scale. We built the company to deliver against an unprecedented set of quality metrics and configured our departments, production oversight, training, and process control systems to ensure conformance to these metrics.
Most importantly, by integrating our customers as key partners, we opened a feedback loop with the most sophisticated examiners of our quality. To this day we work closely with our customers to understand the “critical to quality” metrics of their applications, leveraging those unique requirements to pressure test and continually improve the quality of our products. Our primary quality objective is to be certain that when product leaves Enzymatics and enters a customer’s incoming inspection process that it will pass every single time.
We welcome our partners to audit our manufacturing facilities.
QIAGEN Beverly’s management and employees are committed to manufacturing innovation and exceptional flexibility, with a focus on Quality for the production, sale, and support of products and services for the life science and molecular diagnostic markets. Through the use of our Quality Management System, QIAGEN Beverly will comply with the applicable internal, regulatory, statutory and customer requirements. We commit to maintain the effectiveness of the QMS, which underlies our efforts to also ensure the effectiveness of our products.